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INTRODUCTION
Liposomes are sphere-shaped vesicles consisting of one or more phospholipid bilayers. Liposomes can trap both hydrophobic and hydrophilic compounds, avoid decomposition of the entrapped combinations, and release the entrapped at designated targets. The liposome can be used as a vehicle for administration of nutrients and pharmaceutical drugs. Additionally, food and farming industries have extensively studied the use of liposome encapsulation to grow delivery systems that can entrap unstable compounds (for example, antimicrobials, antioxidants, flavours and bioactive elements) and shield their functionality. Due to their size and hydrophobic and hydrophilic character (besides biocompatibility), liposomes are promising systems for drug delivery 1, 2 . Inspite of its broad applications and advantages, liposomes have a problem of degradation by hydrolysis or oxidation as well as sedimentation, aggregation, or fusion with other liposomes in dispersed system during non-lyophilized storage. Other drawbacks associated with the clinical applications of liposomes include difficulties in large-scale production to obtain a product with adequate physical and chemical stability, low solubility, short half-life and sometimes leakage of encapsulated drug/molecules 3, 4 . Various approaches have been suggest-ed to increase the stability of liposomes, including using appropriate lipid compositions, polymer coating, addition of stabilizing lipids to liposomal structures, preparation of double liposomes and proliposomes and some other innovative methods like lyophilization of liposomal solution to stabilize, reconstitute right before use 4, 5 . Among all these approaches Proliposome approach is most promising.
The review gives an insight on Proliposomes based approach for the development of a stable liposome and explore its various aspects including its formulation components, preparation, characterization and its potential in Proliposomes are a new type of carrier mediated drug delivery system having many benefits over conventional liposomes. The stability of proliposomes is far superior to liposomes making them more suitable for the delivery of drugs. They are a dry, free-flowing, granular material that immediately forms a liposomal dispersion on contact with water or a biological fluid within the body 5,6,7 . Comparative features of Liposomes and Proliposomes is shown in The proliposome approach was developed as a simple, reproducible, and reliable manufacturing technique for largescale production of liposome dispersions. The technology is based upon the intrinsic property of hydrated membrane lipids to form vesicles on contact with water. It involves layering of the phospholipids onto a finely divided particulate support which results in the formation of dry powders.
When the dry powders are hydrated with an aqueous solution followed by gentle mixing, phospholipids on the solid support rapidly disperses to give a liposomal suspension 233 Ars Pharm. 2019; 60(4): 231-240
Proliposomes: An Approach for the Development of Stable Liposome in an aqueous solution 5, 6, 7 . Liposomes can either be formed in vivo under the influence of physiological fluids or can be formed in vitro prior to administration using a suitable hydrating fluid. The liposomes formed on reconstitution are similar to conventional liposomes and more uniform in size 7, 8 . The mechanism of formation of liposome from proliposome is demonstrated in Figure 2 . Proliposomes have been employed as a basis for a number of site-specific drug delivery approaches. Proliposomal formulations suggest increases solubility and bioavailability of some poorly soluble drugs. Being available in dry powder form, they have an additional convenience in transportation, distribution, storage, processing, packaging, providing optimal flexibility, unit dosing as capsule and stable during sterilization. All these advantages make them a promising candidate for industrial production. These versatile delivery systems have potential to be used as a carrier for wide range of active compounds 7,9. 
FORMULATION COMPONENTS FOR PROLIPOSOMES
Formulation of proliposomes involves several components: 
Water soluble carriers
The carriers chosen should have high surface area and porosity so that the amount of carrier required can be easily adjusted to support the lipids. It also allows high surfactant to carrier mass ratio within the preparation of proliposomes.
Since they are water soluble they allow rapid conversion of liposomal dispersion on hydration and by controlling the size of porous powder, relatively narrow range of reconstituted liposomes can be obtained. Some of the carriers used are-Maltodextrin, Mannitol, Sorbitol, Microcrystalline Cellulose, Magnesium Aluminium Silicates, etc 1, 4 .
Solvents
They are used for providing the softness to vesicle membrane. Most commonly used volatile organic solvent or solvent mixtures are ethanol, methanol, ether and chloroform 13 .
METHODS FOR PREPARATION OF PROLIPOSOMES
Various methods are available for the preparation of proliposomes. Careful selection of suitable method for a given formulation is essential since various factors such as vesicle size, size distribution, encapsulation capability and retention of contents are affected by the method of preparation.
Selection of a given method is based on physicochemical characteristics of the drug, desired type of phospholipid(s), 
CHARACTERIZATION OF PROLIPOSOMES
Proliposomes are characterized for morphology, angle of repose, rate of hydration, penetration and permeation studies.
Particle size
Particle size of proliposome is a very important characteristic. Size distribution and surface morphology (smoothness, roundness and aggregates formation) of particles can be studied by scanning electron microscopy (SEM). The deposition of phospholipid on the carrier material is confirmed by illegibility of the image of the carrier material in the formulation of proliposomes 19 .
Hydration Study and Vesicle formation
It is important to determine the formation of liposomal vesicle following hydration of the proliposomal formulation in vitro. The vesicle formation by the particular procedure can be confirmed by optical microscopy. The liposome suspension has to be placed over a glass slide and dried at room temperature, the dry thin film of liposome suspension formed has to be observed for the formation of vesicles 6, 14 .
Measurement of zeta potential
Another characteristic of proliposomes is zeta potential that is of extreme interest. It is a measure of the particle charge, the larger the zeta potential absolute value the larger the amounts of surface charge. Logically, the zeta potential is an index for particle stability. A physically stable proliposomal formulation solely stabilized by electrostatic repulsion will have a ±30mV of minimum zeta potential and this stability helps in preventing aggregation 20 . 
Separation of unentrapped drug

Differential Scanning Calorimetry and Powder X-ray
Diffractometry
Differential scanning calorimetry (DSC) and powder X-ray diffractometry (PXRD) can be used to determine the solid state properties of drug after formulating in to prolipos-omes i.e., changes in its form from crystalline to amorphous. This is especially important when the drug's solubility was improved using proliposomal formulation 22 .
Flow Properties
Flow properties mainly explain content uniformity and handling processing operations and also ease filling. Since it is a solid powder based formulation, it is important to analyse the flow properties in order to translate them into a convenient dosage forms such as tablets or capsules. Flow properties can be assessed by measuring the parameters such as bulk density, tapped density, angle of repose, Carr's compressibility index and Hausner's ratio 23 .
Determination of entrapment (entrapped) efficiency
Entrapment efficiency is carried by hydrating the proliposomes to form liposome dispersion followed by separation of unentrapped drug and determining the amount of drug entrapped. Untrapped or free drug can be separated by using any one of the method described above 24, 25 .
In vitro drug release from proliposomes
In vitro drug release studies for proliposomes can be done by various techniques such as USP dissolution apparatus Type I, Franz diffusion cell, dialysis tubing, reverse dialysis, cellophane dialyzing membrane, keshary-chien diffusion cell and spectrapormolecular porous membrane tubing.
In vitro skin permeation studies can be carried out using flank skin, dorsal skin of albino rabbit, female albino rat (Sprague-Dawley strain), Wistar rat skin (7-9 weeks old) 2, 7, 21, 23, 26, 27 .
Stability studies
The stability studies can be performed by storing the samples at different temperatures like freezing temperature (2-8ºC), room temperature (25±0.5ºC) and higher temperature Table 1 .
Proliposome in Oral delivery
Oral drug delivery continues to be the preferred route of Piroxicam proliposomal gel showed sustain release with enhanced anti-inflammatory activity 38 . 
Proliposome in Mucosal delivery
Proliposome in Ophthalmic delivery
Proliposome in Pulmonary delivery
Proliposomes have been shown to be very promising in the delivery of various types of pulmonary drugs 43 46 . Pulmonary liposomal delivery system of budesonide was prepared and evaluated for sustained release 47 . Liposomal formulation of salbutamol in dry powder form was also developed as sustained release systems for the pulmonary delivery 48 .
Proliposome in Nasal delivery
Nasal drug delivery has received a significant attention in recent years as a convenient and reliable route, not only for local but also for the systemic administration of drugs.
Proliposomes have also shown their potential in nasal drug delivery. They provide combined advantage of a fast onset (surface drug) and prolonged drug action (encapsulated drug) 49 
CONCLUSIONS AND FUTURE PERSPECTIVES
Pro-liposomes are promising drug carriers for the future. 
